APA citiranje

Martinez-Useros, J., Rodriguez-Remirez, M., Borrero-Palacios, A., Moreno, I., Cebrian, A., Gomez del Pulgar, T., . . . Garcia-Foncillas, J. (2014). DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer. BMC Cancer.

Citação norma Chicago

Martinez-Useros, Javier, et al. "DEK Is a Potential Marker for Aggressive Phenotype and Irinotecan-based Therapy Response in Metastatic Colorectal Cancer." BMC Cancer 2014.

MLA citiranje

Martinez-Useros, Javier, et al. "DEK Is a Potential Marker for Aggressive Phenotype and Irinotecan-based Therapy Response in Metastatic Colorectal Cancer." BMC Cancer 2014.